Anaphylaxis
46
8
10
26
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.2%
1 terminated out of 46 trials
96.3%
+9.8% vs benchmark
11%
5 trials in Phase 3/4
19%
5 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (46)
Oral Immunotherapy in Food Allergy in Finland
PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges
Steroid Use in Treatment of Allergic Reactions to Food
Analysis of the Role of IgE Proteoforms in Health and Disease
Diagnosis and Allergen Identification of Perioperative Anaphylaxis
Observation Periods and Biphasic Reaction Risk Factors in Pediatric Emergency Anaphylaxis Cases
Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis
Standardised Drug Provocation Testing in Perioperative Hypersensitivity
Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers
Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges
A Study About the Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis
Comparative Bioavailability of Intranasal Epinephrine
Canadian Anaphylaxis Network- Predicting Recurrence After Emergency Presentation for Allergic REaction
A Registry for the Food Allergy Community
Acquisition and Long-term Observation of Patients With Severe Allergic Reactions
Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Bioavailability of Nasal Epinephrine
Evaluation of Medical Care and Patient's Knowledge About the Behavior to Take on Secondary Prevention of Anaphylaxis